CKPT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CKPT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Checkpoint Therapeutics's interest income for the three months ended in Sep. 2024 was $0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in Sep. 2024 was $0.01 Mil.
The historical data trend for Checkpoint Therapeutics's Interest Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Checkpoint Therapeutics Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Interest Income | Get a 7-Day Free Trial | 0.14 | 0.12 | 0.05 | 0.16 | 0.08 |
Checkpoint Therapeutics Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Interest Income | Get a 7-Day Free Trial | 0.01 | - | - | - | - |
Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.
Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
William Garrett Gray | officer: See Remarks | 2 GANSEVOORT STREET,, 9TH FLOOR, NEW YORK NY 10014 |
Oliviero James F Iii | director, officer: CEO, President and Director | C/O KERYX BIOPHARMACEUTICALS, INC., 750 LEXINGTON AVENUE, NEW YORK NY 10022 |
Fortress Biotech, Inc. | 10 percent owner | 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS FL 33154 |
Michael S Weiss | director | 750 LEXINGTON AVE, NEW YORK NY 10022 |
Neil Herskowitz | director | 2109 BROADWAY, SUITE 206, NEW YORK NY 10023 |
Christian Bechon | director | C/O LFB, 3, AVENUE DES TROPIQUES, LES ULIS, COURTABOEUF I0 91940 |
Barry M Salzman | director | 464 COMMON STREET, SUITE 301, BELMONT MA 02478 |
Scott Boilen | director | 2 SKYLINE DRIVE, HAWTHORNE NY 10532 |
Rosenwald Lindsay A Md | director | 375 PARK AVE, NEW YORK NY 10152 |
David J Horin | officer: Interim CFO | 1270 AVENUE OF THE AMERICAS, 16TH FLOOR, NEW YORK NY 10020 |
From GuruFocus
By Marketwired • 05-28-2024
By GuruFocus News • 11-15-2024
By GuruFocus Research • 08-14-2024
By Marketwired • 08-12-2024
By Marketwired • 06-04-2024
By PRNewswire • 05-30-2024
By Marketwired • 11-12-2024
By PRNewswire • 05-31-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.